Share

IIR document

Popularity and achievements in using whole body cryotherapy (WBC) as a therapy supporting the treatment of multiple sclerosis in Poland.

Number: 0160

Author(s) : MILLER E.

Summary

Multiple sclerosis (MS) affects approximately 3 million people worldwide. The aim of this presentation is to popularise the use of WBC as a therapy supporting the treatment of MS by reducing oxidative stress, severity of symptoms of fatigue syndrome, improving the functional status and quality of life. In Poland, according to the National Health Fund (NFZ) data, the number of reimbursed cryochamber treatments in MS patients remains stable, i.e. about 14,239 services in the group of MS patients out of the total number of about 641,737 per year. This kind of therapy is financed by NFZ as a guaranteed benefit and included by NFZ in the Coordinated Care Programme for MS Patients. The Polish MS Society recommends systemic cryotherapy for people with MS, new NFZ regulations included cryochamber procedures in the catalogue of comprehensive specialist care services for patients with MS.

Available documents

Format PDF

Pages: 4 p.

Available

  • Public price

    20 €

  • Member price*

    Free

* Best rate depending on membership category (see the detailed benefits of individual and corporate memberships).

Details

  • Original title: Popularity and achievements in using whole body cryotherapy (WBC) as a therapy supporting the treatment of multiple sclerosis in Poland.
  • Record ID : 30031559
  • Languages: English
  • Subject: Technology
  • Source: Proceedings of the 26th IIR International Congress of Refrigeration: Paris , France, August 21-25, 2023.
  • Publication date: 2023/08/21
  • DOI: http://dx.doi.org/10.18462/iir.icr.2023.0160

Links


See other articles from the proceedings (492)
See the conference proceedings

Indexing